Skip to content

iRadimed IRMD Q4 2024 Annual earnings

Reported February 13, 2025 · Before market open

Revenue$19.4MBeat by $189.2K
EPS$0.44Miss by $0.01
Revenue estimate$19.2M
EPS estimate$0.45

Next report

Jul 31, 2026 (In 2 days)
Revenue estimate$20.4M
EPS estimate$0.42

Financials

Q4 2024

Income statement

See full
Revenue$19.4M+11.1%
Gross profit$14.8M+10.1%
Operating income$5.8M+12.4%
Net income$5.1M+13.4%
EPS (diluted)$0.40+11.1%

Balance sheet

See full
Cash & equivalents$52.2M+5.0%
Total debt$154.7K-92.4%
Total equity$86.8M+21.6%
Total assets$98.3M+6.7%

Cash flow

See full
Operating cash flow$6.0M+53.0%
CapEx$2.8M+425%
Free cash flow$3.2M-5.4%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$697.04M+16.4%
Enterprise value$644.96M+17.0%
P/E36.2×+1.4×
P/S9.5×+0.4×

Profitability

See full
Gross margin76.9%+0.4pp
Operating margin30%-0.6pp
Net margin26.3%0.0pp
FCF margin24.1%+14.9pp

Returns & leverage

See full
Return on equity24.3%+0.6pp
Debt / equity0.0×
Current ratio8.8×+4.2×

Versus estimates

Ask the moment iRadimed reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did iRadimed report Q4 2024 earnings?
iRadimed (IRMD) reported Q4 2024 earnings on February 13, 2025 before market open.
What were iRadimed's Q4 2024 revenue and EPS?
iRadimed reported revenue of $19.4M and eps of $0.44 for Q4 2024.
Did iRadimed beat estimates in Q4 2024?
Revenue beat the consensus estimate of $19.2M by $189.2K. EPS missed the consensus estimate of $0.45 by $0.01.
Where can I find iRadimed's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-002389) directly on SEC EDGAR. The filing index links above go to sec.gov.